Thomas Grote

Summary

Publications

  1. ncbi Efficacy and safety analysis of epoetin alfa in patients with small-cell lung cancer: a randomized, double-blind, placebo-controlled trial
    Thomas Grote
    Forsyth Regional Cancer Center, Winston Salem, NC 27103, USA
    J Clin Oncol 23:9377-86. 2005
  2. ncbi Combination therapy for chemotherapy-induced nausea and vomiting in patients receiving moderately emetogenic chemotherapy: palonosetron, dexamethasone, and aprepitant
    Thomas Grote
    Derrick L Davis Forsyth Regional Cancer Center, 1010 Bethesda Court, Winston Salem, NC 27103, USA
    J Support Oncol 4:403-8. 2006
  3. ncbi Infusion of palonosetron plus dexamethasone for the prevention of chemotherapy-induced nausea and vomiting
    Julio Hajdenberg
    M D Anderson Cancer Center Orlando, 1400 S Orange Ave, Orlando, Florida 32806, USA
    J Support Oncol 4:467-71. 2006

Detail Information

Publications3

  1. ncbi Efficacy and safety analysis of epoetin alfa in patients with small-cell lung cancer: a randomized, double-blind, placebo-controlled trial
    Thomas Grote
    Forsyth Regional Cancer Center, Winston Salem, NC 27103, USA
    J Clin Oncol 23:9377-86. 2005
    ..This randomized, double-blind, placebo-controlled trial (N93-004) evaluated the effects of epoetin alfa on tumor response to chemotherapy and survival in patients with small-cell lung cancer (SCLC)...
  2. ncbi Combination therapy for chemotherapy-induced nausea and vomiting in patients receiving moderately emetogenic chemotherapy: palonosetron, dexamethasone, and aprepitant
    Thomas Grote
    Derrick L Davis Forsyth Regional Cancer Center, 1010 Bethesda Court, Winston Salem, NC 27103, USA
    J Support Oncol 4:403-8. 2006
    ....
  3. ncbi Infusion of palonosetron plus dexamethasone for the prevention of chemotherapy-induced nausea and vomiting
    Julio Hajdenberg
    M D Anderson Cancer Center Orlando, 1400 S Orange Ave, Orlando, Florida 32806, USA
    J Support Oncol 4:467-71. 2006
    ..The combination was well tolerated. Palonosetron plus dexamethasone given as a pretreatment infusion is effective and safe in preventing acute and delayed CINV in patients receiving moderately emetogenic chemotherapy...